Clinical trialObsNot yet recruiting
Targeting Pathogenic Myelopoiesis in Pancreatic Cancer
- Outcome
- Ongoing
- Phase
- Obs
- Status
- Not yet recruiting
- Study type
- Observational
- Start
- 30 September 2026
- Expected end
- 31 December 2029
- Enrollment
- 100 participants
- Sites
- 0
- Primary outcomes
- Frequency and phenotype of circulating myeloid and progenitor cell populations; Transcriptional profiles of circulating myeloid cells and hematopoietic stem and progenitor cells
- Sponsor
- Other
- Results posted
- No
- Last update
- 17 August 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try